| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8278604 | Journal of the Neurological Sciences | 2014 | 5 Pages |
Abstract
Our study demonstrates that the improvement seen in patients treated with β-adrenergic antagonists is not an effect unique to this class. This supports ongoing trials to determine optimum levels of blood pressure control using multiple classes of antihypertensives.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
J.P. Shoup, J. Winkler, A. Czap, I. Staff, G. Fortunato, L.D. McCullough, L.H. Sansing,